The MAD agreement explains much of the regulatory inaction over the plastic bisphenol A (BPA), for example. Because of MAD, FDA and also its European equivalent, the European Food Safety Authority, have ignored the hundreds of peer-reviewed BPA studies—since they are not GLP— in favor of just two by industry. These two industry studies, whose credibility and conclusions have been publicly disputed by independent scientists, showed no ill effects of BPA.